Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 107, Issue 6, 2013, Pages 372-376

  Bertocchi, Graciela L ^a   Vigliano, Carlos A ^a   Lococo, Bruno G ^a   Petti, Marcos A ^a   Viottib, Rodolfo J ^b  

^a Hospital Eva Peron   (Argentina)

^b Jefe de la divisio'n enfermedad de Chagas   (Argentina)

Author keywords

Benznidazole; Chagas disease; Disease progression; Parasitological cure; Spontaneous seroconversion; Treatment

Indexed keywords

BENZNIDAZOLE;

ADULT; AORTA ROOT; ARTICLE; CHAGAS DISEASE; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; SEROLOGY; TRYPANOSOMA CRUZI;

BENZNIDAZOLE; CHAGAS DISEASE; DISEASE PROGRESSION; PARASITOLOGICAL CURE; SPONTANEOUS SEROCONVERSION; TREATMENT;

ADULT; ANTIPARASITIC AGENTS; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRYPANOSOMA CRUZI;

EID: 84882989819     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trt029     Document Type: Article

References (21)

1. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007;102:75-85.
2. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003;98:577-91.
3. PAHO. Quantitative estimation of Chagas disease in the Americas [in Portuguese]. Montevideo: Pan American Health Organization; 2006.
4. De Andrade ALS, Zicker F, de Oliveira RM et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996;348:1407-13.
5. Sosa Estani S, Segura EL, Ruiz AM et al. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 1998;59:526-9.
6. WHO. Control of Chagas disease, aetiological treatment. Geneva: World Health Organization; 2002. Technical Report Series 905.
7. Bern C, Montgomery SP, Herwaldt BL et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007;298:2171-81.
8. Cossio PM, Diez C, Szarfman A. Chagasic cardiopathy. Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures. Circulation 1974;49:13-21.
9. Teixeira ARL, Santos-Buch CA. The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi A antigens. Immunology 1975;28:401-10.
10. Teixeira ARL, Teixeira ML, Santos-Buch CA. The immunology of Chagas' disease in man. Am J Pathol 1975;80:163-80.
11. Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 1994;127:151-62.
12. Viotti R, Vigliano C, Lococo B et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment. Ann Intern Med 2006;144:724-74.
13. Canc'ado JR. Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop S Paulo 2002;44:29-37.
14. Viotti R, Vigliano C,Álvarez MG et al. Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease. PLoS Negl Trop Dis 2011;5:e1314.
15. PAHO/WHO. Etiological treatment of Chagas disease: Conclusions of a technical consultation [in Portuguese]. Pan American Health Organization/World Health Organization; 1999. Report OPS/HCP/ HCT/140/99.
16. Kuschnir E, Sgammini H, Castro R et al. Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy. Arq Bras Cardiol 1985;45:249-56.
17. Viotti R, Vigliano C. Etiological treatment of chronic Chagas disease: neglected evidence by evidence-base medicine. Expert Rev Anti Infect Ther 2007;5:717-26.
18. Francolino SS, Antunes AF, Talice R et al. New evidence of spontaneous cure in human Chagas disease. Rev Soc Bras Med Trop 2003;36:103-7.
19. Pinto Dias JC, Dias E, Filho OM et al. Further evidence of spontaneous cure in human Chagas disease [in Portuguese]. Rev Soc Bras Med Trop 2008;41:505-6.
20. Sosa-Estani S, Viotti R, Segura E. Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz 2009;104:167-80.
21. Viotti R, Vigliano C, Alvarez MG et al. The impact of socioeconomic conditions on the evolution of chronic Chagas disease [in Spanish]. Rev Esp Cardiol 2009;62:1224-32.